Home › Valeant Pharmaceuticals Intl's (VRX) Hold Rating Reiterated at Morgan Stanley
 

Keywords :   


Valeant Pharmaceuticals Intl's (VRX) Hold Rating Reiterated at Morgan Stanley

2015-12-16 07:40:59| Biotech - Topix.net

's stock had its "hold" rating reiterated by equities researchers at Morgan Stanley in a research note issued to investors on Tuesday, MarketBeat reports. Shares of Valeant Pharmaceuticals Intl traded up 16.41% during midday trading on Tuesday, reaching $109.59.

Tags: rating hold morgan stanley

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Forecast Discussion Number 6
05.11Tropical Storm Rafael Wind Speed Probabilities Number 6
05.11Tropical Storm Rafael Public Advisory Number 6
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Forecast Advisory Number 6
05.11Why colouring clothes has a big environmental impact
05.11Atlantic Tropical Weather Outlook
More »